Free Trial

Order From U.S. Army Fuels Surge In Enovix Stock

Enovix stock price

Key Points

  • Enovix receives a purchase order from the U.S. Army, propelling its stock higher.
  • Analysts maintain a bullish outlook on Enovix, predicting a potential 68% upside in the stock.
  • Short interest remains elevated, adding to the growing confidence among long-term investors.
  • 5 stocks we like better than Enovix.

Shares of the lithium-ion manufacturer, Enovix NASDAQ: ENVX, have added to its impressive run, with stock up 40% in the last month. Just under a month ago, when I first covered Enovix, shares were up 13.5% YTD. Fast forward three weeks, and the stock is now up close to 55% YTD. So what's caused the sharp move in recent weeks, and is the risk: reward still favorable to the long side?

Enovix is a leading manufacturer of advanced lithium-ion batteries in several applications, including vehicles, consumer electronics, and grid storage. Enovix's innovative battery design offers higher energy density, improved safety, and a longer life cycle than traditional lithium-ion batteries. The company's website says, "Enovix is on a mission to power the technologies of the future. Everything from IoT, mobile and computing devices, to the vehicle you drive, needs a batter." And Enovix plans on being the manufacturer of those batteries.

Enovix Receives Order From U.S. Army

On the 27th of June, 2023, shares of Enovix broke out of the longstanding consolidation and traded above-average volume. The surge in price and volume came as the company announced that it received a purchase order to produce battery cells for the U.S. Army.

The company announced the progression of its U.S. Army program, with a commitment to producing commercial cells for use within U.S. Army soldiers' central power source.

Dr. Raj Talluri, President and CEO of Enovix, said: "This achievement is yet another proof point on our journey to scale."

Analysts See 68% Upside

Enovix Marketbeat analyst ratings forecast
Analysts remain bullish on the name, with the consensus rating at a Buy based on eleven analyst ratings. The consensus price target of $31.08 predicts a possible 68% upside in the stock. All eleven analysts covering the name have a Buy rating. Most recently, in May, Robert W. Baird boosted their price target from $64 - $67, predicting a 469% upside.


Short Interest Remains Elevated

Enovix short interest chart
Month over month, the short interest grew from 26.21% to 26.66%, or $416 million to $435 million volume sold short. With the short interest continuing to make new highs and the stock recently breaking out on a positive catalyst, longs will be growing more confident.


The Stock's Recent Performance

enovix stock price chart
Before breaking out, and as previously identified, the stock was trading in a favorable setup. The consolidation near critical resistance provided a unique opportunity if the stock were to break higher on increased volume firmly. It was probable that the stock would break out and experience momentum, especially given the significant short interest, bullish sentiment among analysts, Q1 insider purchases, and favorable technical setup.

After the explosive move above the previous resistance, $15, the stock is now trading near a crucial resistance area, $20. Those looking to get involved should wait for a pullback and higher low as a possible entry as the uptrend and turnaround further develop in the stock.

Should you invest $1,000 in Enovix right now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Technical Analysis, Momentum Trading, Risk Management

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enovix (ENVX)
1.9981 of 5 stars
$9.73+21.2%N/A-6.04Moderate Buy$20.50
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines